During COVID-19, UC San Diego Health expanded telehealth to provide patients with safe and convenient access to appointments with their health care providers. Video visits expanded by more than 50-fold.
UC San Diego researchers have identified small molecules in the blood of asymptomatic pregnant women that may predict risk for preeclampsia, responsible for a significant proportion of maternal and neonatal deaths, low birth weight and is a primary cause of premature birth.
Study finds that microRNA biomarkers in asymptomatic pregnant women might reveal higher risk for the common and serious pregnancy complication; early identification could lead to prevention and better maternal and newborn outcomes
The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites. A QandA with the trial’s team leader: Davey Smith, MD, of UC San Diego School of Medicine.
Orange, Calif. — UCI Health is initiating a clinical study of a drug to treat critically ill COVID-19 patients who face a high mortality rate because of acute inflammation that fills their lungs with fluid, a grave condition that even mechanical ventilation cannot improve. Aviptadil, which has a 20-year history…
Irvine, Calif. — A $2.5-million gift from the John and Mary Tu Foundation to the University of California, Irvine is supporting COVID-19-associated patient care at UCI Health and to advance clinical and translational research across the university campus that is focused on new ways to test for and treat the…
Health Media Contacts
Find the best contact for health-related media inquiries.
